Insights into molecular mechanisms that drive hyperglycemia and T2D: Snail/SNAI1 increases CyclinD1 expression and inhibits gluconeogenesis via transcriptional regulation of Peroxisome proliferator-activated receptor γ coactivator-1α, 14/September/2014, 17.59

Therapeutic insights into the treatment of hippocampal neurodegeneration and memory loss: Stress-induced gene product MiRNA-29 promotes apoptosis of hippocampal neurons and memory loss via down regulation of its target gene, 14/September/2014, 17.36
September 14, 2014
Therapeutic insights into the treatment of autoimmune encephalomyelitis: Cell Cycle-regulated protein E2F3 protects neurons against autoimmune encephalomyelitis via up regulation of Sirtuin-1, 14/September/2014, 21.32
September 14, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Insights into molecular mechanisms that drive  hyperglycemia and T2D: Snail/SNAI1 increases CyclinD1 expression and inhibits gluconeogenesis via transcriptional regulation of Peroxisome proliferator-activated receptor γ coactivator-1α, 14/September/2014, 17.59, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that Snail/SNAI1by suppressing the expression of its target gene, it  inhibits gluconeogenesis.  Thus, pharmacological formulations encompassing “Snail/SNAI1 activators” may be used to treat DM.

* Research cooperation

Comments are closed.